Severe insulin resistance in the setting of therapeutic hypothermia
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Abstract
Background: Hyperglycemia is common in critically ill patients and has been associated with
poor outcomes. The effect of hypothermia, whether induced or spontaneous, on insulin resistance
and hyperglycemia is not well understood and sometimes overlooked.
Objectives: Goals are to review the literature on glucose metabolism and insulin resistance in
patients treated with therapeutic hypothermia (TH) after sudden cardiac arrest (SCA) and also to
present knowledge about the possible effects of hypothermia on glycemic control and insulin
sensitivity.
Methods: We present an example of extreme insulin resistance during the period of therapeutic
hypothermia in a patient who was admitted after a sudden cardiac Arrest. Literature review was
conducted as a Medline/PubMed search. Studies were assessed regarding designs, primary and
secondary efficacy parameters on TH after sudden cardiac arrest and effects on glucose
metabolism.
Results: A 68-year-old male who was admitted after SCA was noted to have extreme insulin
resistance during TH which completely resolved during the rewarming phase of TH. No
randomized, controlled trials were found in the Medline search. Two studies found that there was
an increase in insulin resistance during TH especially during the cooling phase, whereas three
studies found no direct association between TH and blood glucose levels.
Conclusion: There is a possible association between TH and a reversible form of insulin
resistance. More studies are needed. Patients who are treated with TH after SCA may present a
challenge in glucose management.
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Introduction
Therapeutic hypothermia (TH) has resulted in improvements in mortality rates from sudden
cardiac death.1 Literature on the effect of hypothermia on insulin resistance and hyperglycemia is
lacking. We describe a patient who developed transient severe insulin resistance during the
induced hypothermia phase with clear temporal association between low body temperature and
high insulin requirement. We also review the current literature with respect to glucose
metabolism in post cardiac arrest patients undergoing TH.
Case Report
A 68-year old Caucasian man with type 2 diabetes mellitus presented after an out of the hospital
sudden cardiac arrest (SCA). He was admitted after the return of spontaneous circulation
(ROSC) with defibrillator shock and Amiodarone 150 mg administered intravenously for
ventricular fibrillation. Upon arrival to the emergency room, he was found to have ST-elevation

myocardial infarction (STEMI) and was sent to the cardiac catheterization lab where no culprit
lesion was identified. On initial neurological examination, he had minimal response to deep pain
stimuli, inability to follow instructions, no purposeful movements with normal deep tendon
reflexes and muscular tone. Therapeutic hypothermia was initiated and monitored in the
intensive care unit. He also received renal replacement therapy for acute renal injury presumably
due to severe hypoxic end-organ damage. His body mass index was 34 kg/m² with no signs of
Cushing’s syndrome or Acromegaly.
His past medical history was significant for hypertension, hyperlipidemia and coronary artery
disease (he had an angioplasty done 3 years prior to presentation). His home regimen for diabetes
consisted of metformin and NPH insulin (doses were unclear). Initial blood glucose (BG) was
238 mg/dl in the Emergency room. After initiation of therapeutic hypothermia he developed
severe hyperglycemia while on continuous insulin infusion (CII) protocol, reaching a maximum
of 434 mg/dl within the first 24 hours of TH. The hourly intravenous insulin infusion rate
increased to a maximum of 280 units/hour (Figure 1). Eventually his blood glucose reached
target of 140-180 mg/dl during the rewarming phase as his insulin requirements and blood
glucose levels started to decrease. Blood glucose level remained between 80 and 100 mg/dl
without CII after the rewarming phase. He was not receiving enteral or parenteral nutrition.
Baseline laboratory values showed renal impairment with metabolic acidosis. Liver function test
was normal (Table 1).

Table 1. Laboratory results at the time of admission
LAB
VALUE
LAB
(reference range)

VALUE
(reference range)

Sodium (mEq/L)

132 (135 – 145)

Total Bilirubin (mg/dL)

0.5 (0.1 – 1.0)

Potassium (mEq/L)

3.8 (3.3 – 5.1)

AST (U/L)

87 (5 – 37)

Chloride (mmol/L)

100 (96 – 108)

ALT (U/L)

56 (15 – 65)

CO2 (mmol/L)

18 (21 – 32)

49 (50 – 120)

BUN (mg/dL)

43 (7 – 18)

Alkaline phosphatase
(U/L)
pH

Creatinine (mg/dL)

2.3 (0.6 – 1.1)

Hemoglobin (g/dL)

11.7 (12.0 – 15.0)

Calcium (mg/dL)

6.8 (8.5 – 10.1)

Lactate (mmol/L)

1.9 (0.4 – 2.0)

Anion Gap (mmol/L)

13 (4-16)

Hemoglobin A1c (%)

7.7 (4.0 – 6.0)

Albumin (g/dL)

1.9 (2.9 – 4.9)

WBC (x1000/mm3)

8.7 (4.8 – 10.8)

7.20 (7.35 – 7.45)

Figure 1. Blood glucose levels and insulin infusion rates during therapeutic hypothermia. Adm =
admission; TH= onset of therapeutic hypothermia

The insulin autoantibodies were negative and insulin level during the plateau phase of
hypothermia was extremely high (>1000 Miu/ml), indicating extreme insulin resistance. There
was no evidence of any other medical intervention or condition that might have confounded our
results (like sepsis or administration of glucocorticoids). After discontinuation of therapeutic
hypothermia, his insulin requirements and his blood glucose decreased rapidly as illustrated in
figure 1. After that he did not require any insulin to keep his blood glucose at target for the last 5
days of his hospitalization before he died of anoxic brain damage.
Discussion
Our patient demonstrated evidence of extreme insulin resistance in the setting of therapeutic
hypothermia, followed by a marked improvement with the return of normal body temperature.
There was a clear temporal association between body temperature and insulin requirement which
may suggest that hypothermia might have contributed to the extreme insulin resistance in our
patient.

Hyperglycemia is common after CA and is associated with unfavorable neurologic outcomes and
mortality.2-4 Insulin resistance (IR) has also been observed in cardiac arrest patients treated with
TH.5-7
In an observational study involving 103 patients who underwent TH for SCA, Kim et al showed
that early achievement of target BG level was significantly associated with better survival and
favorable neurologic outcomes.8 In this study, those patients who reached the target range within
4 hours were more likely to survive and to be discharged with favorable neurologic outcomes,
regardless of other confounding factors such as pre-arrest variables, insulin requirements, and
previous history of diabetes. The study did not show a clear association between TH and insulin
resistance.
Ettleson et al conducted a retrospective chart review of 62 post-cardiac arrest patients
undergoing TH in a tertiary institution between September 2005 and April 2008.9 In their study
they found increased mortality associated with increased blood glucose levels after SCA but
before initiation of TH or an insulin drip. TH had no independent effect on BG.
Other studies did show an association between TH and insulin resistance. In a study of 200 post
cardiac arrest patients, Pri and coworkers found a significant increase in insulin sensitivity and
decrease in insulin-sensitivity variability as persons transitioned from the cool to warm phase of
TH.10 The study by Cueni-Villoz et al showed that besides acute stress from cardiac arrest,
therapeutic hypothermia has a role in causing hyperglycemia and high glucose variability
through a reversible increase in insulin resistance during the cooling phase.11
Forni et al showed in a retrospective study that there was a significant increase in mean blood
glucose in the cooling phase as compared to rewarming (9.16±3.22 mmol/L vs. 6.54 ±2.45
mmol/L; P<0.01) with higher insulin requirements (15.2±16.1 vs. 7 ±12.5 units/h).12
Conclusion
We presented a patient with extreme insulin resistance that developed during the cooling phase
of therapeutic hypothermia and resolved completely during the rewarming phase. In our patient
we reduced and subsequently stopped insulin infusion during the warming phase in a rapid way
(from >250 units per hour to zero) to avoid hypoglycemia which can be detrimental in a patient
with anoxic brain injury (Figure 1). Review of the literature on this topic showed conflicting data
regarding TH as an independent risk factor for hyperglycemia and insulin resistance. It is
possible that certain individuals are more prone to the metabolic effects of hypothermia. Further
studies are needed to confirm the association and to identify the predictors for such severe form
of insulin resistance so that a specialized insulin infusion protocol can be used. Physicians and
nurses need to be aware of this potential association and the potential need for a modified
intravenous insulin protocol for patients who develop severe insulin resistance during the cooling
phase of TH.
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